Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Deficiencies”

667 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 667 results

Not applicableLooking for participantsNCT04784364
What this trial is testing

Biologics And Clinical Immunology Cohort at Sinai

Who this might be right for
Immunological DiseaseAutoimmune DiseasesPrimary Immune Deficiency
Icahn School of Medicine at Mount Sinai 800
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Large-scale testing (Phase 3)Study completedNCT01963143
What this trial is testing

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinaemia+1 more
Bio Products Laboratory 48
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Study completedNCT01083316
What this trial is testing

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 35
Not applicableStudy completedNCT00086476
What this trial is testing

Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Who this might be right for
Blood Coagulation Disorders
National Human Genome Research Institute (NHGRI) 3
Large-scale testing (Phase 3)Study completedNCT03988426
What this trial is testing

Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 25
Not applicableLooking for participantsNCT06565078
What this trial is testing

A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants with Primary Immunodeficiency

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 100
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Testing effectiveness (Phase 2)Looking for participantsNCT06919003
What this trial is testing

Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)

Who this might be right for
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 180
Large-scale testing (Phase 3)Study completedNCT01461018
What this trial is testing

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 22
Testing effectiveness (Phase 2)Looking for participantsNCT03266640
What this trial is testing

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Who this might be right for
Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Large-scale testing (Phase 3)Looking for participantsNCT06076642
What this trial is testing

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 39
Not applicableUnknownNCT03668288
What this trial is testing

Tolerance and Patients' Satisfaction With IGHy

Who this might be right for
Secondary or Primary Immunodeficiency
CHU de Reims 20
Not applicableStudy completedNCT02716103
What this trial is testing

Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 45
Testing effectiveness (Phase 2)UnknownNCT04371939
What this trial is testing

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Testing effectiveness (Phase 2)Study completedNCT00003406
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Cancer Treatment Centers of America 30
Large-scale testing (Phase 3)Study completedNCT01386658
What this trial is testing

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 32
Large-scale testing (Phase 3)Study completedNCT04842643
What this trial is testing

An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

Who this might be right for
Primary Immunodeficiency Disease
Takeda 12
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Load More Results